@article{HintzscheJastrowKleineOstmannetal.2012,
  author    = {Hintzsche, Henning and Jastrow, Christian and Kleine-Ostmann, Thomas and K{\"a}rst, Uwe and Schrader, Thorsten and Stopper, Helga},
  title     = {Terahertz electromagnetic fields (0.106 THz) do not induce manifest genomic damage in vitro},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-76268},
  year      = {2012},
  abstract  = {Terahertz electromagnetic fields are non-ionizing electromagnetic fields in the frequency range from 0.1 to 10 THz. Potential applications of these electromagnetic fields include the whole body scanners, which currently apply millimeter waves just below the terahertz range, but future scanners will use higher frequencies in the terahertz range. These and other applications will bring along human exposure to these fields. Up to now, only a limited number of investigations on biological effects of terahertz electromagnetic fields have been performed. Therefore, research is strongly needed to enable reliable risk assessment. Cells were exposed for 2 h, 8 h, and 24 h with different power intensities ranging from 0.04 mW/cm2 to 2 mW/cm2, representing levels below, at, and above current safety limits. Genomic damage on the chromosomal level was measured as micronucleus formation. DNA strand breaks and alkali-labile sites were quantified with the comet assay. No DNA strand breaks or alkali-labile sites were observed as a consequence of exposure to terahertz electromagnetic fields in the comet assay. The fields did not cause chromosomal damage in the form of micronucleus induction.},
  subject      = {Toxikologie},
  language  = {en}
}
@article{FoertschHuppMaetal.2011,
  author    = {F{\"o}rtsch, Christina and Hupp, Sabrina and Ma, Jiangtao and Mitchell, Timothy J. and Maier, Elke and Benz, Roland and Iliev, Asparouh I.},
  title     = {Changes in Astrocyte Shape Induced by Sublytic Concentrations of the Cholesterol-Dependent Cytolysin Pneumolysin Still Require Pore-Forming Capacity},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-69084},
  year      = {2011},
  abstract  = {Streptococcus pneumoniae is a common pathogen that causes various infections, such as sepsis and meningitis. A major pathogenic factor of S. pneumoniae is the cholesterol-dependent cytolysin, pneumolysin. It produces cell lysis at high concentrations and apoptosis at lower concentrations. We have shown that sublytic amounts of pneumolysin induce small GTPase-dependent actin cytoskeleton reorganization and microtubule stabilization in human neuroblastoma cells that are manifested by cell retraction and changes in cell shape. In this study, we utilized a live imaging approach to analyze the role of pneumolysin's pore-forming capacity in the actin-dependent cell shape changes in primary astrocytes. After the initial challenge with the wild-type toxin, a permeabilized cell population was rapidly established within 20-40 minutes. After the initial rapid permeabilization, the size of the permeabilized population remained unchanged and reached a plateau. Thus, we analyzed the non-permeabilized (non-lytic) population, which demonstrated retraction and shape changes that were inhibited by actin depolymerization. Despite the non-lytic nature of pneumolysin treatment, the toxin's lytic capacity remained critical for the initiation of cell shape changes. The non-lytic pneumolysin mutants W433F-pneumolysin and delta6-pneumolysin, which bind the cell membrane with affinities similar to that of the wild-type toxin, were not able to induce shape changes. The initiation of cell shape changes and cell retraction by the wild-type toxin were independent of calcium and sodium influx and membrane depolarization, which are known to occur following cellular challenge and suggested to result from the ion channel-like properties of the pneumolysin pores. Excluding the major pore-related phenomena as the initiation mechanism of cell shape changes, the existence of a more complex relationship between the pore-forming capacity of pneumolysin and the actin cytoskeleton reorganization is suggested.},
  subject      = {Toxikologie},
  language  = {en}
}
@phdthesis{Sieber2009,
  author    = {Sieber, Maximilian},
  title     = {Evaluation of 1H-NMR and GC/MS-based metabonomics for the assessment of liver and kidney toxicity},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-43052},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2009},
  abstract  = {For the assessment of metabonomics techniques for the early, non-invasive detection of toxicity, the nephrotoxins gentamicin (s.c. administration of 0, 60 and 120 mg/kg bw 2x daily for 8 days), ochratoxin A (p.o. administration of 0, 21, 70 and 210 µg/kg bw 5 days/week for 90 days) and aristolochic acid (p.o. administration of 0, 0.1, 1.0 and 10 mg/kg bw for 12 days) were administered to rats and urine samples were analyzed with 1H-NMR and GC/MS. Urine samples from the InnoMed PredTox project were analyzed as well, thereby focusing on 1H-NMR analysis and bile duct necrosis as histopathological endpoint. 1H-NMR analysis used water supression with the following protocol: 1 M phosphate buffer, D2O as shift lock reagent, D4-trimethylsilyl­propionic acid as chemical shift reference, noesygppr1d pulse sequence (Bruker). For multivariate data analysis, spectral intensity was binned into 0.04 ppm wide bins. GC/MS analysis of urine was carried out after protein precipitation with methanol, drying, derivatization with methoxyamine hydrochloride in pyridine and with methyl(trimethylsilyl)­trifluoroacetamide on a DB5-MS column using EI ionization. The chromatograms were prepared for multivariate data analysis using the R-program based peak picking and alignment software XCMS version 2.4.0. Principal component analysis (PCA) to detect and visualize time-point and dose-dependent differences between treated animals and controls and orthogonal projection to latent structures discriminant analysis (OPLS-DA) for identification of potential molecular markers of toxicity was carried out using SIMCA P+ 11.5 1H-NMR-based markers were identified and quantified with the Chenomx NMR Suite, GC/MS based markers were identified using the NIST Mass Spectral Database and by co-elution with authentic reference standards. PCA of urinary metabolite profiles was able to differentiate treated animals from controls at the same time as histopathology. An advantage over classical clinical chemistry parameters regarding sensitivity could be observed in some cases. Metabonomic analysis with GC/MS and 1H-NMR revealed alterations in the urinary profile of treated animals 1 day after start of treatment with gentamicin, correlating with changes in clinical chemistry parameters and histopathology. Decreased urinary excretion of citrate, 2-oxoglutarate, hippurate, trigonelline and 3-indoxylsulfate increased excretion of 5-oxoproline, lactate, alanine and glucose were observed. Ochratoxin A treatment caused decreased excretion of citrate, 2-oxoglutarate and hippurate and and increased excretion of glucose, myo-inositol, N,N-dimethylglycine, glycine, alanine and lactate as early as 2 weeks after start of treatment with 210µg OTA/kg bw, correlating with changes in clinical chemistry parameters and histopathology. Integration of histopathology scores increased confidence in the molecular markers discovered. Aristolochic acid treatment resulted in decreased urinary excretion of citrate, 2-oxoglutarate, hippurate and creatinine as well as increased excretion of 5-oxoproline, N,N-dimethylglycine, pseudouridine and uric acid. No alterations in clinical chemistry parameters or histopathology were noted.Decreased excretion of hippurate indicates alterations in the gut microflora, an effect that is expected as pharmacological action of the aminoglycoside antibiotic gentamicin and that can also be explained by the p.o. administration of xenobiotica. Decreased Krebs cycle intermediates (citrate and 2-oxoglutarate) and increased lactate is associated with altered energy metabolism. Increased pseudouridine excretion is associated with cell proliferation and was observed with aristolochic acid and ochratoxin A, for which proliferative processes were observed with histopathology. 5-oxoproline and N,N-dimethylglycine can be associated with oxidative stress. Glucose, a marker of renal damage in clinical chemistry, was observed for all three nephrotoxins studied. Single study analysis with PCA of GC/MS chromatograms and 1H-NMR spectra of urine from 3 studies conducted within the InnoMed PredTox project showing bile duct necrosis revealed alterations in urinary profiles with the onset of changes in clinical chemistry and histopathology. Alterations were mainly decreased Krebs cycle intermediates and changes in the aromatic gut flora metabolites, an effect that may result as a secondary effect from altered bile flow. In conclusion, metabonomics techniques are able to detect toxic lesions at the same time as histopathology and clinical chemistry. The metabolites found to be altered are common to most toxicities and are not organ-specific. A mechanistic link to the observed toxicity has to be established in order to avoid confounders such as body weight loss, pharmacological effects etc. For pattern recognition purposes, large databases are necessary.},
  subject      = {Toxikologie},
  language  = {en}
}
@phdthesis{Troesken2005,
  author    = {Tr{\"o}sken, Eva-Regina},
  title     = {Toxicological evaluation of azole fungicides in agriculture and food chemistry},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-17016},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2005},
  abstract  = {Azole sind wichtige Chemikalien, die als Fungizide in der Landwirtschaft und der Medizin eingesetzt werden. Auch als Zytostatika in der Humanmedizin finden sie Anwendung. Die fungizide Wirkung beruht auf der Hemmung der Lanosterol-14\&\#945;-Demethylase (CYP51), die die Demethylierung von Lanosterol zum „Follicular Fluid Meiosis Activating Steroid (FF-MAS)" katalysiert. F{\"u}r Pilze ist das sp{\"a}ter resultierende Ergosterol ein essentieller Bestandteil der Zellmembran. Exponierten Pilzen fehlt Ergosterol was zu einem Zusammenbruch der Zellmembran f{\"u}hrt. S{\"a}ugetiere k{\"o}nnen Cholesterol, das sp{\"a}tere Produkt der Lanosterol-14\&\#945;-Demethylierung, das zur Synthese von z.B. Gallens{\"a}uren und Sexualhormonen n{\"o}tig ist, mit der Nahrung aufnehmen. FF-MAS und das resultierende T-MAS (Testis Meiosis Activating Steroids), die direkten Produkte der CYP51 katalysierten Reaktion, wirken als Meiose-aktivierende Steroide auf Ovarien und Hoden und werden nicht mit der Nahrung aufgenommen. Eine Hemmung der CYP51 Aktivit{\"a}t k{\"o}nnte das endokrine System beeinflussen und wird daher als unerw{\"u}nschte Nebenwirkung der Azole betrachtet. Aromatase (CYP19) katalysiert die Demethylierung von Testosteron zu {\"O}stradiol und wird durch Azole gehemmt. Die Verringerung der {\"O}strogenspiegel durch CYP19-Inhibition ist das Wirkprinzip der als Zytostatika genutzten Azole, bei den Fungiziden wird es als unerw{\"u}nschte Nebenwirkung angesehen. Ein ideales Azol sollte Pilz-CYP51 stark inhibieren, aber sowohl humanes CYP19 wie auch humanes CYP51 sollten durch ein solches Azol nicht inhibiert werden. Ein ideales Azol-Zytostatikum sollte eine starke inhibitorische Potenz gegen{\"u}ber humanem CYP19 aufweisen, hingegen sollten humanes und Pilz-CYP51 nicht inhibiert werden. Ziel dieser Arbeit war es nun festzustellen: sind Fungizide und Antimykotika starke Inhibitoren von Pilz-CYP51? Zeigen Fungizide und Antimykotika keine Aktivit{\"a}t gegen{\"u}ber humanem CYP19 und humanem CYP51? Sind Zytostatika starke Inhibitoren von humanem CYP19? Zeigen Zytostatika keine Aktivit{\"a}t gegen{\"u}ber humanem CYP51 und Pilz-CYP51? Die inhibitorische Potenz von 22 Azolen, aus den drei Anwendungsgebieten, wurden an vier Systemen getestet: i) an humanem CYP19 und einem fluoreszierenden Pseudosubstrat, ii) an CYP19 und Testosteron als Substrat, iii) an humanem CYP51 und iv) Candida albicans CYP51 und Lanosterol als Substrat. Die Produktbildung wurde mittels Hochdruckfl{\"u}ssigkeitschromatographie gekoppelter Tandem-Massenspektrometrie nach Photosprayionisation gemessen. Das humane CYP51 wurde von „BD Gentest Cooperation" zur Verf{\"u}gung gestellt. Ein katalytisch aktiver Enzymkomplex bestehend aus der Lanosterol-14\&\#945;-Demethylase von Candida albicans und der Oxidoreduktase von Candida tropicalis, wurde im Baculovirussystem exprimiert. Ein Vergleich der inhibitorischen Wirkst{\"a}rke der Substanzen auf menschliches CYP19 und CYP51 und Pilz-CYP51 zeigt, dass einige Azole das erw{\"u}nschte Bild zeigen. Dazu geh{\"o}ren die beiden Zytostatika Fadrozol und Letrozol, sowie Fluconazol und Itraconazol, zwei Antimykotika aus der Humanmedizin, und einige Fungizide z.B. Cyproconazol und Hexaconazol. Ein unerw{\"u}nschtes Bild zeigen z.B. Prochloraz, Bifonazol, Ketoconazol und Miconazol. Sieben Azole weisen ein gemischtes Bild an inhibitorischen Wirkst{\"a}rken auf. Um einen modellartigen Eindruck der R{\"u}ckst{\"a}nde von Azolen in Lebensmitteln zu erhalten, wurde eine auf LC-ESI-MS/MS basierende R{\"u}ckstandsanalytik f{\"u}r Azole im Wein entwickelt. Alle gefunden R{\"u}ckst{\"a}nde lagen unterhalb der beh{\"o}rdlich festgelegten R{\"u}ckstandsh{\"o}chstmengen. Um die inhibitorische Wirkung der Azole auf die verschiedenen Enzymsysteme in einem gr{\"o}ßeren Zusammenhang zu bringen, wurden die IC50 Werte mit Expositionsdaten von Bauern, maximalen Plasmaspiegeln in Patienten nach der Einnahme von Antimykotika und mit Expositionsgrenzwerten f{\"u}r die Langzeitaufnahme von Pflanzenschutzmittelr{\"u}ckst{\"a}nden („Acceptable Daily Intake Levels", ADI) verglichen. Basierend auf den dargestellten Ergebnissen k{\"o}nnen folgende Schlussfolgerungen gezogen werden. Das Risiko f{\"u}r landwirtschaftliche Arbeiter durch Exposition gegen{\"u}ber Azolfungiziden kann im Bezug auf menschliches CYP19 und CYP51 als vernachl{\"a}ssigbar eingestuft werden, wenn die entsprechenden Sicherheitsvorkehrungen getroffen werden. Im medizinischen Bereich muss grunds{\"a}tzlich der Einsatz von Bifonazol, Miconazol und Ketoconazol mit Blick auf die hohe inhibitorische Potenz gegen{\"u}ber menschlichem CYP19 und 51 kritisch betrachtet werden. Unter der Annahme, dass die ADI Werte eingehalten werden, stellen R{\"u}ckst{\"a}nde auf Lebensmitteln in Bezug auf die genannten Enzymsysteme keine Bedrohung f{\"u}r den Verbraucher da. Die Inhibition von CYP19 muss als St{\"o}rung des Hormonsystems angesehen werden. Die Bedeutung von FF-MAS und T-MAS im endokrinen System muss noch abschließend gekl{\"a}rt werden und damit auch die Frage, wie viel Bedeutung der Inhibition von menschlichem CYP51 beigemessen werden muss.},
  subject      = {Azole},
  language  = {en}
}
@article{FischerLutz1994,
  author    = {Fischer, W. H. and Lutz, Werner K.},
  title     = {Short communication : Mouse skin papilloma formation by chronic dermal application of 7,12-dimethylbenz[a]anthracene is not reduced by diet restriction},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-60644},
  year      = {1994},
  abstract  = {No abstract available},
  subject      = {Toxikologie},
  language  = {en}
}
@article{GrunickePyerinEisenbrandetal.1994,
  author    = {Grunicke, H. and Pyerin, W. and Eisenbrand, G. and Havemann, K. and Rabes, H. M. and Molling, K. and Schwab, M. and Lutz, Werner K. and Wahrendorf, J. and Schirrmacher, V.},
  title     = {7th International Symposium of the Division of Experimental Cancer Research (AEK) of the German Cancer Society : [Meeting report]},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-60651},
  year      = {1994},
  abstract  = {No abstract available},
  subject      = {Toxikologie},
  language  = {en}
}
@article{StopperKuehnelPodschun1994,
  author    = {Stopper, Helga and K{\"u}hnel, A. and Podschun, B.},
  title     = {Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63383},
  year      = {1994},
  abstract  = {The rate limiting step in 5-fluorouracil catabolism is catalyzed by the enzyme dihydropyrimidine dehydrogenase. Since degradation of 5-fluorouracil decreases its efficacy in chemotherapy, the inhibition of its catabolism is a promising tool. We investigated the formation of micronuclei in vitro in mouse L5178Y cells. 5-fluorouracil induced an increase in micronucleus frequency, which could significantly be enhanced by the concurrent application of 2,6-dihydroxypyridine, an inhibitor of dihydropyrimidine dehydrogenase. The 5-fluorouracil concentration necessary to reach maximal genotoxic effects could be reduced to half in the presence of inhibitor. 2,6-Dihydroxypyridine alone and the naturally occuring enzyme substrate uracil did not induce micronucleus formation. Combined application of the chemotherapeutic agent 5-fluorouracil and an inhibitor of its could reduce side-effects by lowering the effective dose of the active drug. With this study we provide further support for the usefulness of this concept.},
  subject      = {Toxikologie},
  language  = {en}
}
@article{StopperEckertSchiffmannetal.1994,
  author    = {Stopper, Helga and Eckert, I. and Schiffmann, D. and Spencer, D. L. and Caspary, W. J.},
  title     = {Is micronucleus induction by aneugens an early event leading to mutagenesis?},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63390},
  year      = {1994},
  abstract  = {This study was designed to investigate a previously unidentified potential mechanism for mutation induction as well as to clarify a biological comequence of micronucleus formation. We compared the induction of micronuclei with mutation inductioo as measured by trißuorothymidine (TFI') resistance in mouse L5178Y cells using four aneugens: colcemid, diethylstilbestrol, griseofulvin and vioblastine. AU four compounds induced micronuclei which appeared in the first cell cycle after treatment. More than 85\% of the micronuclei induced by each compound stained positive for the presence of kinetochores implying that the micronuclei contained wbole cbromosomes. However, these same compounds were unable to induce TFf resistance under tbree different treatment regimes. We concluded that tbese compounds, under conditions where tbey induce primarily kinetochore positive micronuclel, were not able to induce mutations. Thus, the induction of micronuclei containing wbole chromosomes barborlog a select.able gene is not an early event leadlog to mutations in these cells.},
  subject      = {Toxikologie},
  language  = {en}
}
@article{KlotzKrotecGripentrogetal.1994,
  author    = {Klotz, Karl-Norbert and Krotec, K. L. and Gripentrog, J. and Jesaitis, A. J.},
  title     = {Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-60466},
  year      = {1994},
  abstract  = {The cytoskeleton and/or membrane skeleton has been implicated in the regulation of N-formyl peptide receptors. The coupling of these chemotactic receptors to the membrane skeleton was investigated in plasma membranes from unstimulated and desensitized human neutrophils using the photoreactive agonist N-formyl-met-leu-phelys-N\(^6\)-[\(^{125}\)I]2(p-azidosalicylamido)ethyl-1,3'-dithiopropionate (fMLFK-[\(^{125}\)I]ASD). When membranes of unstimulated cells were solubilized in Triton-X 100, a detergent that does not disrupt actin filaments, only 50\% of the photoaffinity-labeled receptors were solubilized sedimenting in sucrose density gradients at a rate consistent with previous reports. The remainder were found in the pellet fraction along with the membrane skeletal actin. Solubilization of the membranes in the presence of p-chloromercuriphenylsulfonic acid, elevated concentrations of KCI, or deoxyribonuclease I released receptors in parallel with actin. When membranes from neutrophils, desensitized by incubation with fMLFK-e 251]ASD at 15°C, were solubilized, nearly all receptors were recovered in the pellet fraction. lncubation of cells with the Iigand at 4°C inhibited desensitization partially and prevented the conversion of a significant fraction of receptors to the form associated with the membrane skeletal pellet. ln these separations the photoaffinity-labeled receptors not sedimenting to the pellet cosedimented with actin. Approximately 25\% of these receptors could be immunosedimented with antiactin antibodies suggesting that N-formyl peptide receptors may interact directly with actin. These results are consistent with a regulatory role for the interaction of chemotactic N-formyl peptide receptors with actin of the membrane skeleton.},
  subject      = {Toxikologie},
  language  = {en}
}
@article{KlotzJesaitis1994,
  author    = {Klotz, Karl-Norbert and Jesaitis, A. J.},
  title     = {Neutrophil chemoattractant receptors and the membrane skeleton},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-60471},
  year      = {1994},
  abstract  = {Signal transduction via receptors for N-formylmethionyl peptide chemoattractants (FPR) on human neutrophils is a highly regulated process which involves participation of cytoskeletal elements. Evidence exists suggesting that the cytoskeleton and/or the membrane skeleton controls the distributJon of FPR in the plane of the plasma membrane, thus controlling the accessibility of FPR to different proteins in functionally distinct domains. In desensitized cells, FPR are restricted todomains which are depleted of G proteins but enriched in cytoskeletal proteins such as actin and fodrin. Thus, the G protein signal transduction partners of FPR become inaccessible to the agonist-occupied receptor, preventing cell activation. The mechanism of interaction of FPR with the membrane skeleton is poorly understood but evidence is accumulating that suggests a direct binding of FPR (and other receptors) to cytoskeletal proteins such as actin.},
  subject      = {Toxikologie},
  language  = {en}
}